Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
Current Oncology (Toronto, Ont.)|June 24, 2011
Models of care for early-stage breast cancer in CanadaY Madarnas, A A Joy, S Verma, et al.Nucleosides, Nucleotides & Nucleic Acids|April 25, 2000
Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1K A Graham, J Leithoff, I R Coe, et al.Journal of the National Cancer Institute|November 5, 1999
Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transportersJ R Mackey, S Y Yao, K M Smith, et al.Oncogenesis|April 5, 2013
Regulation of subcellular distribution and oncogenic potential of nucleophosmin by plakoglobinL Lam, Z Aktary, M Bishay, et al.Oncogene|January 27, 2010
Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1Z Aktary, K Chapman, L Lam, et al.Blood|September 6, 2001
Expression of high Km 5'-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemiaC M Galmarini, K Graham, X Thomas, et al.Current Oncology (Toronto, Ont.)|March 5, 2008
Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working GroupJ R Mackey, M Clemons, M A Côté, et al.Cancer Research|October 10, 1998
Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell linesJ R Mackey, R S Mani, M Selner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-line chemotherapy for metastatic breast cancerJ M Nabholtz, J R Mackey, M Smylie, et al.Oncology (Williston Park, N.Y.)|August 1, 1997
Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancerJ M Nabholtz, M Smylie, J R Mackey, et al.Pageof 7